Efg Asset Management (North America) Corp. Edgewise Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 104,386 shares of EWTX stock, worth $1.55 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
104,386
Previous 41,338
152.52%
Holding current value
$1.55 Million
Previous $1.1 Million
108.16%
% of portfolio
0.4%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$222 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$132 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$97 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$91.2 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$89.1 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $936M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...